Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: A comparison of CT and three MRI sequences

Cerebrovascular Diseases

Volumn 29, Issue 6, 2010, Pages 597-604

  Renou, P ^a,b,c   Sibon, I ^b   Tourdias, T ^c   Rouanet, F ^b   Rosso, C ^a   Galanaud, D ^a   Drier, A ^a   Coudert, M ^a   Deltour, S ^a   Crozier, S ^a   Dormont, D ^a   Samson, Y ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Fédération des Neurosciences Cliniques   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

ECASS classification; Haemorrhagic transformation; Reproducibility; Stroke; Thrombolysis

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REPRODUCIBILITY;

COHORT STUDIES; DATABASES, FACTUAL; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951066413     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312867     Document Type: Article

References (23)

1. Lansberg MG, Albers GW, Wijman CA: Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007; 24: 1-10.
2. Marti-Fabregas J, Bravo Y, Cocho D, Marti- Vilalta JL, Diaz-Manera J, San Roman L, Puig M, Blanco M, Castellanos M, Millan M, Roquer J, Obach V, Maestre J: Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Cerebrovasc Dis 2007; 23: 85-90.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
4. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European- Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251.
5. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRIbased 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
6. Hill MD, Buchan AM: Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. Cmaj 2005; 172: 1307-1312.
7. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
8. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-517.
9. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R: Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001; 32: 1330-1335.
10. Christoforidis GA, Slivka A, Mohammad Y, Karakasis C, Avutu B, Yang M: Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 2007; 38: 1799-1804.
11. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD: Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke 2007; 38: 75-79.
12. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, Ringleb AP, Lorenzano S, Manelfe C, Bozzao L: Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280-2284.
13. Thomalla G, Sobesky J, Kohrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Rother J, Schellinger PD: Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 h. Stroke 2007; 38: 313-318.
14. Trouillas P, von Kummer R: Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke 2006; 37: 556-561.
15. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
16. Solling C, Hjort N, Ashkanian M, Ostergaard L, Andersen G: Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window. Cerebrovasc Dis 2009; 27: 223-229.
17. Arnould MC, Grandin CB, Peeters A, Cosnard G, Duprez TP: Comparison of CT and three MR sequences for detecting and categorizing early (48 hours) hemorrhagic transformation in hyperacute ischemic stroke. AJNR Am J Neuroradiol 2004; 25: 939-944.
18. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A, Olkers P, Hirsch JG, Heiland S, Wilde P, Jansen O, Rother J, Hacke W, Sartor K: Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004; 35: 502-506.
19. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, Butman JA, Patronas N, Alger JR, Latour LL, Luby ML, Baird AE, Leary MC, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca JP, Davis S, Dunn B, Todd JW, Ezzeddine MA, Haymore J, Lynch JK, Davis L, Warach S: Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004; 292: 1823-1830.
20. Kent DM, Hinchey J, Price LL, Levine SR, Selker HP: In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous? Stroke 2004; 35: 1141-1146.
21. Burgess RE, Warach S, Schaewe TJ, Copenhaver BR, Alger JR, Vespa P, Martin N, Saver JL, Kidwell CS: Development and validation of a simple conversion model for comparison of intracerebral hemorrhage volumes measured on CT and gradient recalled echo MRI. Stroke 2008; 39: 2017-2020.
22. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K: A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999; 30: 765-768. (Pubitemid 29156365)
23. Mak HK, Yau KK, Chan BP: Prevalence-adjusted bias-adjusted kappa values as additional indicators to measure observer agreement. Radiology 2004; 232: 302-303.